We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Login or sign up: Please either login to Lexology or sign up for our free legal news service to be able to register for this event.

Medicinal cannabis and CBD products – navigating Ireland’s regulatory framework

Mason Hayes & Curran


The Irish government has passed the Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) Regulations 2019, which allow the use of cannabis to treat persons with certain medical conditions under the care of a medical consultant. As a result of this legislation, statistics indicate that up to 50,000 Irish patients could be prescribed cannabis within the next four years.

This webinar examines the regulatory landscape governing medicinal cannabis and the changes that have been introduced to the regulatory framework in Ireland by the new regulations. In addition, we will examine the import and supply of medicinal cannabis into Ireland and the application process to the Health Products Regulation Authority.

We will also consider the regulation of cannabidiol (CBD) products and products containing CBD in several industries, including cosmetics and food and beverages. The webinar will provide legal insight for manufacturers navigating the regulatory issues arising with manufacturing and supplying these products and discuss some key risks that companies must be aware of, including those relating to advertising campaigns and claims being made about these products.

This talk is aimed at in-house counsel and those in private practice in the life sciences and products industries.


Michaela Herron

Michaela Herron advises clients in the pharmaceutical, medical device (including software medical device), healthcare, digital health, cosmetic and general consumer produce sectors on various regulatory compliance matters, including regulatory approval, labelling, traceability, safety and liability issues. She has advised clients on enforcement action, including the defence of criminal prosecutions, the implementation and coordination of produce withdrawals and product recalls and rectification strategies in multiple jurisdictions. She has also acted on behalf of clients in significant commercial disputes, group product liability litigation, inquests, injunctive relief and judicial review proceedings.

Wendy Hederman

Wendy Hederman leads the food, agriculture and beverage team at Mason Hayes & Curran. She advises clients on all supply chain and sales matters. She works closely with manufacturing and retail companies on bringing new products to market – from research and development to the manufacturing stage. She also provides counsel to companies on matters relating to distribution, import, sales and compliance with regulatory issues of labelling, advertising, food safety and consumer protection issues. More recently, she has advised extensively on the rules regarding cannabis and CBD products. She also advises businesses on outsourcings, IT agreements and all contracts for establishing and growing a business. Her career includes a decade as an in-house counsel, including seven years working with the legal team in Diageo/Guinness.


Michaela Herron
Wendy Hederman


17 October 2019
14:00 - 14:55 UTC
55 min